|
|
FDADocs 5/9/2008 | 0 (0) | 51 | 0 | 0 | English
MEMORANDUMDEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCHDATE: FROM:March 3, 2006 Tho... ... more>>
FDADocs 5/9/2008 | 0 (0) | 51 | 1 | 0 | English
Script - An Introduction to the Improved FDA Prescription Drug LabelingWelcome and thank you for participating in the Food and Drug Administration, Center for Drug Evaluation and Research ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 51 | 1 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health ServiceFood and Drug Administration Rockville, MD 20857NDA 18-662/S046Hoffman-La Roche Inc. Attention: Joanna Wau... ... more>>
FDADocs 5/9/2008 | 0 (0) | 51 | 0 | 0 | English
Vaccine Safety: An FDA PerspectiveKaren Midthun, M.D. Deputy Director Center for Biologics Evaluation and Research U.S. FDAAmerican Course on Drug Development and Regulatory Sciences Washington ... more>>
FDADocs 5/12/2008 | 0 (0) | 51 | 0 | 0 | English
Hepatotoxicity Steering Committee Contact Sheet Revised February 2006NAME Mark Avigan FDA Jeffrey... Cirangle Consultant Joe DeGeorge Merck Tricia Desantis Johnson & Johnson Yvonne Dragan FDA/NCTR ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 50 | 0 | 0 | English
Guidance for Industry and FDA Staff Premarket Approval Application Filing ReviewDocument issued on: May 1, 2003 This document supersedes PMA Filing Decisions (P90-2), dated May 18, 1990 and PMA ... more>>
FDADocs 5/9/2008 | 0 (0) | 49 | 2 | 0 | English
FDA Regulations and Recommendations for Failure InvestigationsHoi-may Wong, BS, MT(ACSP)SBB Blood and Plasma Branch Division of Blood Applications, FDA, CBER, OBRRFDA Workshop Licensure of ... more>>
FDADocs 5/8/2008 | 0 (0) | 48 | 1 | 0 | English
Safety PageHow FDA reviews drug namesEditors??? note: According to a 1999 Institute of Medicine report, approximately 7,000 deaths occur yearly due to medication errors. To help save lives, the ... more>>
FDADocs 5/9/2008 | 0 (0) | 48 | 0 | 0 | English
FDA Approved Labeling Text for NDA 21-717/S-005 & S-008 FINAL-Label-23-JAN-2004 PROVIGIL?? (modafinil) Tablets [C-IV] DESCRIPTION PROVIGIL (modafinil) is a wakefulness-promoting agent for oral ... more>>
FDADocs 5/9/2008 | 0 (0) | 47 | 0 | 0 | English
FDA Forum handheld Doppler safetyPage 1FDA Forum handheld Doppler safetyPage 2FDA Forum handheld Doppler safetyPage 3FDA Forum handheld Doppler safetyPage 4FDA ... more>>
sammyc2007 4/23/2008 | 0 (0) | 47 | 2 | 0 | English
The Academic Anesthesia Department and The FDALex Schultheis, M.D., Ph.D.Division of Anesthetic, Analgesic, and Rheumatology Products CDER/FDAThe content of this talk does not necessarily ... more>>
FDADocs 5/9/2008 | 0 (0) | 46 | 0 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health ServiceFood and Drug Administration Rockville, MD 20857NDA 18-662/S046Hoffman-La Roche Inc. Attention: Joanna Wau... ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 46 | 0 | 0 | English
Guidance for Industry and FDA StaffGuidance Document for Vascular Prostheses 510(k) SubmissionsDocument issued on: November 1, 2000This document supercedes Guidance Document for Vascular ... more>>
FDADocs 5/5/2008 | 0 (0) | 45 | 1 | 0 | English
FDA Regulations and Recommendations for Failure InvestigationsHoi-may Wong, BS, MT(ACSP)SBB Blood and Plasma Branch Division of Blood Applications, FDA, CBER, OBRRFDA Workshop Licensure of ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 45 | 0 | 0 | English
Industry and FDA StaffDocument Issued on: November 2, 2007This document supersedes the... contact Chester T. Reynolds, 240-276-0157 or mailto:Chester.Reynolds@fda.hhs.govU.S. Department ... more>>
| | | |
| results / page 15/25/50 |
Page: 4 of 33
|
4...
|
|